Albany Molecular Research Inc (NASDAQ:AMRI)

16.08
Delayed Data
As of 11:40am ET
 -0.09 / -0.56%
Today’s Change
13.73
Today|||52-Week Range
23.95
-1.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-32.3M-3.8M12.7M--
 
 
 
 
Depreciation18.0M17.3M15.9M--
 
 
 
 
Total Other Cash Flow24.4M10.6M4.7M--
 
 
 
 
Funds From Operations9.1M27.5M33.4M--
 
 
 
 
Funds From/For Other Operating Expenses10.6M12.2M5.2M--
 
 
 
 
Net Cash Flow - Operating Activities-1.5M15.3M28.2M--
 
 
 
 
 
InvestingIncrease In Investments-817.0K0.000.00--
 
 
Decrease In Investments16.0M213.0K0.00--
 
 
 
Capital Expenditures-10.8M-9.9M-11.1M--
 
 
 
 
Fixed Asset Disposal0.00447.0K300.0K--
 
 
 
Net Cash Flow Investing4.0M-9.8M-11.2M--
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.005.0M145.3M--
 
 
 
Long Term Debt Reduction-7.4M-2.8M-775.0K--
 
 
 
 
Net Proceeds Stock Sale671.0K0.0023.1M--
 
 
 
Common Preferred Redeemed0.000.00-164.0K--
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.00531.0K3.0M--
 
 
 
Other Uses - Financing270.0K5.2M33.6M--
 
 
 
 
Net Cash Flow - Financing-7.0M-2.5M136.9M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.3M288.0K-1.2M--
 
 
 
 
 
Net Change In Cash-4.5M3.0M153.8M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account